Clinical Trial: Hidabicin hydrochloride, subcutaneous injection of cytarabine and G-CSF Treatment of Myelodysplastic Syndrome IB2 with Lisatokela and adult secondary acute myeloid leukemia or elderly acute myeloid leukemia A prospective, multicenter, exploratory study of leukemia (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Hidabicin hydrochloride, subcutaneous injection of cytarabine and G-CSF Treatment of Myelodysplastic Syndrome IB2 with Lisatokela and adult secondary acute myeloid leukemia or elderly acute myeloid leukemia A prospective, multicenter, exploratory study of leukemia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131661

Registration Time: 2026/09/04

Type: Interventional study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337444

Published by HT Digital Content Services w...